These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 714996)

  • 1. Preliminary observations on the ultrastructural modifications of the freeze-cleaved circulating platelets surface in hypercholesterolemic rabbits treated with AD6.
    Weber G; Bianciardi G; Pierli C
    Pharmacol Res Commun; 1978 Sep; 10(8):739-46. PubMed ID: 714996
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural modifications of the platelet plasma membrane in vascular diseases and the effect of a carbochromen derivative as studied by freeze-fracture and computer measurement.
    Bianciardi G; Vittoria A; Toti P; Franchi M; Martelli G; Di Perri T; Weber G
    Atherosclerosis; 1986 Nov; 62(2):173-8. PubMed ID: 2948512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increase of the openings of the surface-connected canalicular system in weakly stimulated platelets is prevented by a carbochromen derivative. A computerized morphometric analysis of freeze-etched human platelet plasma-membrane.
    Bianciardi G; Toti P; Weber G
    Pharmacol Res Commun; 1987 Sep; 19(9):579-89. PubMed ID: 3432323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating platelets plasma-membrane of normocholesterolemic and hypercholesterolemic rabbits tested with aspirin: a freeze etching study of the platelet plasma-membrane "protuberances".
    Weber G; Bianciardi G; Toti P
    Pharmacol Res Commun; 1980 Jan; 12(1):49-55. PubMed ID: 7384164
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
    Hakim G; Fiorentini D; Falasca A; Prosdocimi M; Rossi CA
    Experientia; 1988 Mar; 44(3):226-8. PubMed ID: 2832208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
    Socini A; Petroni A; Colli S; Colombo C; Galli C
    Pharmacol Res Commun; 1982 Mar; 14(3):189-97. PubMed ID: 7048340
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular aspects of cloricromene (AD6) distribution in human platelets and its pharmacological effects.
    Travagli RA; Zatta A; Banzatto N; Finesso M; Mariot R; Tessari F; Prosdocimi M
    Thromb Res; 1989 May; 54(4):327-38. PubMed ID: 2763271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies with the freeze etching method on circulating blood platelets in patients with dyslipemia and in experimental hypercholesteremia. Preliminary note].
    Weber G; Bertelli E; Lungarella G; Bianciardi G
    Arch De Vecchi Anat Patol; 1976 Apr; 61(1):69-75. PubMed ID: 1026213
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
    Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Porcellati S; Costantini V; Prosdocimi M; Pistolesi R; Porrovecchio P; Nenci GG; Goracci G
    Thromb Res; 1987 Jul; 47(1):15-24. PubMed ID: 3116710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
    Porcellati S; Costantini V; Prosdocimi M; Stasi M; Pistolesi R; Nenci GG; Goracci G
    Agents Actions; 1990 Mar; 29(3-4):364-73. PubMed ID: 2111085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Prosdocimi M; Finesso M; Tessari F; Gorio A; Languino LR; de Gaetano G; Dejana E
    Thromb Res; 1985 Aug; 39(4):399-409. PubMed ID: 3840290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
    Luzzatto G; Fabris F; Dal Bo Zanon R; Girolami A
    Arzneimittelforschung; 1986 Jun; 36(6):972-3. PubMed ID: 2943294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
    Zanetti A; Zatta A; Prosdocimi M; Dejana E
    Eur J Pharmacol; 1986 Aug; 128(1-2):119-27. PubMed ID: 2944757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The action of AD6 on experimental arrhythmias and on action potentials of cardiac fibers.
    Bertolino M; Prosdocimi M; Aporti F; Finesso M; Gorio A
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):66-78. PubMed ID: 3753098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet plasma membrane changes in human type IIa hypercholesterolemia.
    Bianciardi G; Weber G; Toti P; Widhalm K; Sinzinger H
    Appl Pathol; 1986; 4(4):253-9. PubMed ID: 3606887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the platelet surface charge in rabbits with experimental hypercholesterolemia.
    Lupu C; Calb M
    Atherosclerosis; 1988 Jul; 72(1):77-82. PubMed ID: 3214461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural observation of openings of open canalicular system on the membrane surface of human platelet by freeze-etching method (author's transl)].
    Arimori S; Sumitomo K
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):569-72. PubMed ID: 696197
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus.
    Weber G; Bianciardi G; Toti P; Massari P; Orlando P
    Pharmacol Res Commun; 1985 Feb; 17(2):129-35. PubMed ID: 3158006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
    Resag K; Melzer G; Nitz RE
    Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.